Your browser doesn't support javascript.
loading
Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection.
Tio, Martin; Rai, Rajat; Ezeoke, Ogochukwu M; McQuade, Jennifer L; Zimmer, Lisa; Khoo, Chloe; Park, John J; Spain, Lavinia; Turajlic, Samra; Ardolino, Luke; Yip, Desmond; Goldinger, Simone M; Cohen, Justine V; Millward, Michael; Atkinson, Victoria; Kane, Alisa Y; Ascierto, Paolo A; Garbe, Claus; Gutzmer, Ralf; Johnson, Douglas B; Rizvi, Hira A; Joshua, Anthony M; Hellmann, Matthew D; Long, Georgina V; Menzies, Alexander M.
Afiliación
  • Tio M; Melanoma Institute Australia, Sydney, Australia. Electronic address: mtio0565@uni.sydney.edu.au.
  • Rai R; Melanoma Institute Australia, Sydney, Australia.
  • Ezeoke OM; Memorial Sloan Kettering Cancer Center, New York, USA.
  • McQuade JL; MD Anderson Cancer Center, Houston, USA.
  • Zimmer L; University of Duisburg-Essen Hospital, Heidelberg, Germany.
  • Khoo C; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Park JJ; Crown Princess Mary Cancer Centre, Sydney, Australia; Westmead Hospital, Sydney, Australia.
  • Spain L; Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK.
  • Turajlic S; Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK; Francis Crick Institute, London, UK.
  • Ardolino L; St Vincents Hospital, Sydney, Australia.
  • Yip D; The Canberra Hospital, Canberra, Australia; ANU Medical School, Australian National University, Canberra, Australia.
  • Goldinger SM; University Hospital Zurich, Zurich, Switzerland.
  • Cohen JV; Massachusetts General Hospital, Boston, USA.
  • Millward M; Sir Charles Gairdner Hospital, Perth, Australia.
  • Atkinson V; Princess Alexandra Hospital, Brisbane, Australia.
  • Kane AY; Liverpool Hospital, Sydney, Australia; Garvan Institute, Sydney, Australia.
  • Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.
  • Garbe C; University of Tubingen, Tubingen, Germany.
  • Gutzmer R; Hannover Medical School, Hannover, Germany.
  • Johnson DB; Vanderbilt Ingram Cancer Center, Nashville, USA.
  • Rizvi HA; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Joshua AM; Melanoma Institute Australia, Sydney, Australia; St Vincents Hospital, Sydney, Australia; University of New South Wales, Sydney, Australia.
  • Hellmann MD; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Long GV; Melanoma Institute Australia, Sydney, Australia; The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia.
  • Menzies AM; Melanoma Institute Australia, Sydney, Australia; The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia.
Eur J Cancer ; 104: 137-144, 2018 11.
Article en En | MEDLINE | ID: mdl-30347289
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Hepatitis B Crónica / Hepatitis C Crónica / Terapia Molecular Dirigida / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Receptores de Trasplantes / Antineoplásicos Inmunológicos / Inmunoterapia / Proteínas de Neoplasias Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Eur J Cancer Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Hepatitis B Crónica / Hepatitis C Crónica / Terapia Molecular Dirigida / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Receptores de Trasplantes / Antineoplásicos Inmunológicos / Inmunoterapia / Proteínas de Neoplasias Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Eur J Cancer Año: 2018 Tipo del documento: Article